Division of Experimental Pathology, Department of Pathology and Immunology, University of Pittsburgh Medical Center, 3550 Terrace Street, Scaife Hall S733, Pittsburgh, PA, 15261, USA.
Cancer Immunol Immunother. 2012 Feb;61(2):223-230. doi: 10.1007/s00262-011-1138-8. Epub 2011 Nov 8.
The tumor microenvironment is a pivotal factor in tumorigenesis, and especially in progression, as the pathogenesis of cancer critically depends on the complex interactions between various microenvironmental components. A key component of the tumor immunoenvironment is the infiltration of immune cells, which has been proven to play a dual role in tumor growth and progression. This Janus two-faced function of the tumor immunoenvironment is seen in tumor infiltration by T cells, which correlates with improved patient survival, but also with the homing of multiple subsets of immunoregulatory cells that inhibit the antitumor immune response. Regulatory dendritic cells (regDCs) have recently been shown to be induced by tumor-derived factors and represent a new and potentially important player in supporting tumor progression and suppressing the development of antitumor immune responses. Our recent data reveal that different tumor cell lines produce soluble factors that induce polarization of conventional DCs into regDCs, both in vitro and in vivo. These regDCs can suppress the proliferation of pre-activated T cells and are phenotypically and functionally different from their precursors as well as the classical immature conventional DCs. Understanding the biology of regDCs and the mechanisms of their formation in the tumor immunoenvironment will provide a new therapeutic target for re-polarizing protumorigenic immunoregulatory cells into proimmunogenic effector cells able to induce and support effective antitumor immunity.
肿瘤微环境是肿瘤发生的关键因素,特别是在进展过程中,因为癌症的发病机制严重依赖于各种微环境成分之间的复杂相互作用。肿瘤免疫环境的一个关键组成部分是免疫细胞的浸润,事实证明,免疫细胞的浸润在肿瘤生长和进展中起着双重作用。肿瘤免疫微环境的这种两面神作用表现在肿瘤浸润 T 细胞中,这与改善患者生存相关,但也与多种免疫调节细胞的归巢相关,这些细胞抑制抗肿瘤免疫反应。最近已经证明,肿瘤衍生因子可诱导调节性树突状细胞(regDC)的产生,这使其成为支持肿瘤进展和抑制抗肿瘤免疫反应发展的新的潜在重要参与者。我们最近的数据表明,不同的肿瘤细胞系在体外和体内产生可溶性因子,诱导常规树突状细胞向 regDC 极化。这些 regDC 可抑制预激活的 T 细胞增殖,其表型和功能与前体以及经典的不成熟常规树突状细胞不同。了解 regDC 的生物学及其在肿瘤免疫环境中的形成机制将为重新极化促肿瘤免疫调节细胞为能够诱导和支持有效抗肿瘤免疫的促免疫效应细胞提供新的治疗靶点。